vs
Side-by-side financial comparison of Allegiant Travel CO (ALGT) and PERRIGO Co plc (PRGO). Click either name above to swap in a different company.
PERRIGO Co plc is the larger business by last-quarter revenue ($1.1B vs $732.4M, roughly 1.5× Allegiant Travel CO). Allegiant Travel CO runs the higher net margin — 5.8% vs -127.8%, a 133.6% gap on every dollar of revenue. On growth, Allegiant Travel CO posted the faster year-over-year revenue change (4.8% vs -2.5%). Over the past eight quarters, Allegiant Travel CO's revenue compounded faster (11.0% CAGR vs 1.3%).
Allegiant Air, styled as allegiant, is an American low-cost airline headquartered in Las Vegas, Nevada. The airline focuses on serving leisure traffic from small and medium-sized cities which it considers to be underserved, using an ultra low-cost business model with minimal inclusions in fares and a greater number of add-on fees.
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...
ALGT vs PRGO — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $732.4M | $1.1B |
| Net Profit | $42.5M | $-1.4B |
| Gross Margin | — | 32.6% |
| Operating Margin | 11.1% | -116.0% |
| Net Margin | 5.8% | -127.8% |
| Revenue YoY | 4.8% | -2.5% |
| Net Profit YoY | 32.4% | -3093.9% |
| EPS (diluted) | $2.30 | $-10.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $732.4M | — | ||
| Q4 25 | $595.5M | $1.1B | ||
| Q3 25 | $494.1M | $1.0B | ||
| Q2 25 | $617.9M | $1.1B | ||
| Q1 25 | $616.8M | $1.0B | ||
| Q4 24 | $553.6M | $1.1B | ||
| Q3 24 | $489.0M | $1.1B | ||
| Q2 24 | $594.5M | $1.1B |
| Q1 26 | $42.5M | — | ||
| Q4 25 | $31.9M | $-1.4B | ||
| Q3 25 | $-43.6M | $7.5M | ||
| Q2 25 | $-65.2M | $-8.4M | ||
| Q1 25 | $32.1M | $-6.4M | ||
| Q4 24 | $-216.2M | $-44.4M | ||
| Q3 24 | $-36.8M | $-21.0M | ||
| Q2 24 | $13.7M | $-108.4M |
| Q1 26 | — | — | ||
| Q4 25 | — | 32.6% | ||
| Q3 25 | — | 36.1% | ||
| Q2 25 | — | 34.4% | ||
| Q1 25 | — | 37.6% | ||
| Q4 24 | — | 33.9% | ||
| Q3 24 | — | 37.2% | ||
| Q2 24 | — | 37.0% |
| Q1 26 | 11.1% | — | ||
| Q4 25 | 11.2% | -116.0% | ||
| Q3 25 | -5.5% | 7.0% | ||
| Q2 25 | -10.9% | 4.3% | ||
| Q1 25 | 10.5% | 4.5% | ||
| Q4 24 | -47.7% | 10.0% | ||
| Q3 24 | -5.4% | 7.4% | ||
| Q2 24 | 5.9% | -2.5% |
| Q1 26 | 5.8% | — | ||
| Q4 25 | 5.4% | -127.8% | ||
| Q3 25 | -8.8% | 0.7% | ||
| Q2 25 | -10.5% | -0.8% | ||
| Q1 25 | 5.2% | -0.6% | ||
| Q4 24 | -39.1% | -3.9% | ||
| Q3 24 | -7.5% | -1.9% | ||
| Q2 24 | 2.3% | -10.2% |
| Q1 26 | $2.30 | — | ||
| Q4 25 | $1.82 | $-10.23 | ||
| Q3 25 | $-2.41 | $0.05 | ||
| Q2 25 | $-3.62 | $-0.06 | ||
| Q1 25 | $1.73 | $-0.05 | ||
| Q4 24 | $-12.12 | $-0.32 | ||
| Q3 24 | $-2.05 | $-0.15 | ||
| Q2 24 | $0.75 | $-0.79 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $902.1M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | $2.9B |
| Total Assets | — | $8.5B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $902.1M | — | ||
| Q4 25 | $805.7M | — | ||
| Q3 25 | $956.7M | $432.1M | ||
| Q2 25 | $842.8M | $454.2M | ||
| Q1 25 | $878.6M | $409.9M | ||
| Q4 24 | $781.1M | $558.8M | ||
| Q3 24 | $759.3M | $1.5B | ||
| Q2 24 | $791.9M | $542.8M |
| Q1 26 | — | — | ||
| Q4 25 | $1.7B | — | ||
| Q3 25 | $1.8B | — | ||
| Q2 25 | $1.8B | — | ||
| Q1 25 | $1.7B | — | ||
| Q4 24 | $1.6B | — | ||
| Q3 24 | $1.8B | — | ||
| Q2 24 | $1.7B | — |
| Q1 26 | — | — | ||
| Q4 25 | $1.1B | $2.9B | ||
| Q3 25 | $1.0B | $4.4B | ||
| Q2 25 | $1.1B | $4.5B | ||
| Q1 25 | $1.1B | $4.4B | ||
| Q4 24 | $1.1B | $4.3B | ||
| Q3 24 | $1.3B | $4.6B | ||
| Q2 24 | $1.3B | $4.5B |
| Q1 26 | — | — | ||
| Q4 25 | $4.2B | $8.5B | ||
| Q3 25 | $4.4B | $10.1B | ||
| Q2 25 | $4.4B | $10.1B | ||
| Q1 25 | $4.5B | $9.8B | ||
| Q4 24 | $4.4B | $9.6B | ||
| Q3 24 | $4.8B | $11.2B | ||
| Q2 24 | $4.9B | $10.4B |
| Q1 26 | — | — | ||
| Q4 25 | 1.60× | — | ||
| Q3 25 | 1.76× | — | ||
| Q2 25 | 1.68× | — | ||
| Q1 25 | 1.57× | — | ||
| Q4 24 | 1.48× | — | ||
| Q3 24 | 1.36× | — | ||
| Q2 24 | 1.30× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $175.4M |
| Free Cash FlowOCF − Capex | — | $148.6M |
| FCF MarginFCF / Revenue | — | 13.4% |
| Capex IntensityCapex / Revenue | — | 2.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $145.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $112.2M | $175.4M | ||
| Q3 25 | $-6.1M | $51.7M | ||
| Q2 25 | $92.2M | $75.9M | ||
| Q1 25 | $191.4M | $-64.5M | ||
| Q4 24 | $84.4M | $312.6M | ||
| Q3 24 | $17.3M | $42.2M | ||
| Q2 24 | $68.9M | $9.5M |
| Q1 26 | — | — | ||
| Q4 25 | $90.4M | $148.6M | ||
| Q3 25 | $-121.7M | $29.8M | ||
| Q2 25 | $-10.5M | $56.7M | ||
| Q1 25 | $116.9M | $-90.0M | ||
| Q4 24 | $24.0M | $274.9M | ||
| Q3 24 | $-28.7M | $15.1M | ||
| Q2 24 | $7.0M | $-18.9M |
| Q1 26 | — | — | ||
| Q4 25 | 15.2% | 13.4% | ||
| Q3 25 | -24.6% | 2.9% | ||
| Q2 25 | -1.7% | 5.4% | ||
| Q1 25 | 19.0% | -8.6% | ||
| Q4 24 | 4.3% | 24.2% | ||
| Q3 24 | -5.9% | 1.4% | ||
| Q2 24 | 1.2% | -1.8% |
| Q1 26 | — | — | ||
| Q4 25 | 3.7% | 2.4% | ||
| Q3 25 | 23.4% | 2.1% | ||
| Q2 25 | 16.6% | 1.8% | ||
| Q1 25 | 12.1% | 2.4% | ||
| Q4 24 | 10.9% | 3.3% | ||
| Q3 24 | 9.4% | 2.5% | ||
| Q2 24 | 10.4% | 2.7% |
| Q1 26 | — | — | ||
| Q4 25 | 3.51× | — | ||
| Q3 25 | — | 6.89× | ||
| Q2 25 | — | — | ||
| Q1 25 | 5.96× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 5.03× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ALGT
| Passenger | $671.8M | 92% |
| Third party products | $42.3M | 6% |
| Fixed fee contracts | $18.1M | 2% |
| Resort and other | $175.0K | 0% |
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
